Virus News and Research

Latest Virus News and Research

SARS-CoV-2 self-amplifying mRNA vaccine demonstrates cellular and humoral immune responses

Researchers from the US recently reported the preclinical development of a self-amplifying mRNA (SAM) vaccine that encodes a prefusion-stabilized SARS-CoV-2 spike glycoprotein.

12 Nov 2021

Xanthohumol as a potent pan-inhibitor for various coronaviruses

Researchers from China reported the results of their study aimed at finding an effective Mpro inhibitor since Mpro is the best drug target to fight SARS-CoV-2 infection.

12 Nov 2021

Impact of mutations on binding affinity of SARS-CoV-2 variants with ACE2 and existing antibodies

Researchers explained their analysis of the mechanisms that trigger the docking of SARS-CoV-2 variants to ACE2 and the antibodies, referred to as protein-protein docking.

12 Nov 2021

How safe is it to travel on public transport amid COVID-19?

The authors extended this research by proposing a time-varying weighted Public Transportation Encounter Network that modeled the COVID-19 infectious process observed on public transport.

12 Nov 2021

INTEGRA’s VOYAGER helps HIV researchers get more results in significantly less time

INTEGRA’s VOYAGER adjustable tip spacing pipette is supporting crucial experimental work in longitudinal HIV studies.

From INTEGRA Biosciences 12 Nov 2021

Study may pave the way for a more personalized approach to COVID-19 diagnosis and treatment

Using some of the most advanced molecular sequencing tools available to evaluate COVID-19 rapid autopsy tissues, researchers have identified four major regulatory pathways, specific molecular effectors behind COVID-19 symptoms, and differences that drive diverging clinical courses among individual patients.

11 Nov 2021

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

A team of scientists describe the safety and response to REGEN-COV® for COVID-19 patients with immunodeficiency-associated antibody disorders.

11 Nov 2021

Research shows link between exercise and better mental health

Kaiser Permanente research published on November 11 in Preventive Medicine showed people who exercised more during the initial lockdown period of the COVID-19 pandemic experienced less anxiety and depression than those who didn't exercise.

11 Nov 2021

UK Government opens large COVID testing facility in Edinburgh

The center, located at 2 Gilmore Park (EH3 9FN), is part of the largest network of diagnostic testing facilities created in British history.

11 Nov 2021

More than 11.4 million people in the UK receive COVID-19 booster jabs

The vital booster program has reached another milestone as more than 11.4 million people in the UK have now received their top-up jabs to maintain protection ahead of the winter months.

11 Nov 2021

University of Oxford begins Phase I trial to test Ebola vaccine

The University of Oxford have begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers - with the first vaccinations taking place today (Thursday, 11 November).

11 Nov 2021

New Delta sublineage shows no additional resistance to neutralization

Researchers are attempting to determine the ability of this new sublineage to avoid neutralization by antibodies elicited from vaccination.

11 Nov 2021

Immunity following COVID-19 vaccination and natural infection in India

The researchers evaluated immune response markers in a cross-section of people from the Indian state of West Bengal, including those vaccinated with either Covishield or Covaxin, the unvaccinated cohort, and the naturally infected.

11 Nov 2021

Association between SARS-CoV-2 infections and areal level deprivation and ethnicity in England

A new study from the UK shows that the presence of inequality favors a heavier impact and that this showed dynamic changes as policies changed and newer virus variants emerged.

11 Nov 2021

Phage-like particle system provides a platform for quick and easy vaccine generation

In this study, researchers report on the development of a monovalent lambda PLP-based vaccine against SARS-CoV-2 or MERS-Cov through decoration with the spike RBD proteins from either virus.

11 Nov 2021

Surveillance approaches to monitor the presence of SARS-CoV-2 in a fully vaccinated population

Researchers at the University of Calgary Health Technology Assessment Unit investigated scientific evidence on various surveillance and testing methods to monitor the presence of the virus in a vaccinated population.

10 Nov 2021

New discovery could lead to the creation of a pan-coronaviruses vaccine

Next generation vaccines for Covid-19 should aim to induce an immune response against 'replication proteins', essential for the very earliest stages of the viral cycle, concludes new research carried out by UCL scientists.

10 Nov 2021

New insights on how future face masks may work

Building better air filters could help head off the next pandemic. At the 74th Annual Meeting of the APS Division of Fluid Dynamics, scientists will present the latest results on how future face masks may work, what happens when masks get wet, and why improper mask usage can sometimes be worse than no mask at all.

10 Nov 2021

First detection of SARS-CoV-2 remdesivir resistance in an immunocompromised patient

A research group from the US (led by experts from Yale University School of Medicine) recently presented a case of an immunocompromised female patient with acquired deficiency of B lymphocytes who subsequently developed a protracted course of the infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

10 Nov 2021

Newly discovered RNA molecule protects mice from emerging SARS-CoV-2 variants

Researchers at Yale School of Medicine have discovered that an RNA molecule that stimulates the body's early antiviral defense system can protect mice from a range of emerging SARS-CoV-2 variants.

10 Nov 2021

Virus News and Research

Latest Virus News and Research

SARS-CoV-2 self-amplifying mRNA vaccine demonstrates cellular and humoral immune responses

Xanthohumol as a potent pan-inhibitor for various coronaviruses

Impact of mutations on binding affinity of SARS-CoV-2 variants with ACE2 and existing antibodies

How safe is it to travel on public transport amid COVID-19?

INTEGRA’s VOYAGER helps HIV researchers get more results in significantly less time

Study may pave the way for a more personalized approach to COVID-19 diagnosis and treatment

Analysis of immunodeficient patients granted REGEN-COV under compassionate use COVID-19 program

Research shows link between exercise and better mental health

UK Government opens large COVID testing facility in Edinburgh

More than 11.4 million people in the UK receive COVID-19 booster jabs

University of Oxford begins Phase I trial to test Ebola vaccine

New Delta sublineage shows no additional resistance to neutralization

Immunity following COVID-19 vaccination and natural infection in India

Association between SARS-CoV-2 infections and areal level deprivation and ethnicity in England

Phage-like particle system provides a platform for quick and easy vaccine generation

Surveillance approaches to monitor the presence of SARS-CoV-2 in a fully vaccinated population

New discovery could lead to the creation of a pan-coronaviruses vaccine

New insights on how future face masks may work

First detection of SARS-CoV-2 remdesivir resistance in an immunocompromised patient

Newly discovered RNA molecule protects mice from emerging SARS-CoV-2 variants

A new way of characterising biomolecules eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in